Navigation Links


People in Medical Technology

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

SCOTTSDALE, Ariz., July 15 /PRNewswire-USNewswire/ -- Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease . Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the c...

New Weight Loss Hope for People with Diabetes

In Clinical Test, NutriSystem D Leads to Weight Loss, Lower Blood Sugar and Improved A1C HORSHAM, Pa., April 21 /PRNewswire-FirstCall/ -- NutriSystem (Nasdaq: NTRI ), a leading weight loss program that delivers to your door, today announced the launch of new NutriSystem D, a weight loss pro...

New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions

Study was conducted with 274 adults with intellectual disabilities currently receiving funding from a state developmental disability agency WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- The Supports Intensity Scale (SIS) assessment tool can effectively predict funding for people with intelle...

Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder

ROCHESTER, Minn., Feb. 11 /PRNewswire-USNewswire/ -- In a study published in The American Journal of Psychiatry , a team of researchers led by Mayo Clinic psychiatrist Mark Frye, M.D., attempted to identify what factors make some people with bipolar depression more likely to experience treatment-...

Good Medicine: Smarter Smartphones for People With Chronic Disease

CHICAGO, Jan. 8 /PRNewswire/ -- If you are taking prescription medicine and forgot to take it today, you're not alone. Half of the people taking prescription medicine don't take it as prescribed. The reasons are varied -- they forget, are busy with other priorities, or make a conscious decisio...

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall/ --GlaxoSmithKline (NYSE: GSK ) today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immu...

Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin

PARIS, September 10 /PRNewswire-FirstCall/ -- - Abstracts 186 and 1003 Sanofi-aventis announced today that results from two studies, GINGER and LACE, presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) demonstrated that a basal-bolus insulin re...

Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees

Delegates Join World Vision, ONE to Build Hope and Give Help MINNEAPOLIS, Sept. 2 /PRNewswire-USNewswire/ -- Delegates to the Republican Party Convention are sending a message to the most vulnerable communities around the world including evacuees in the Gulf Coast region and those suffer...

New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease

Mutation Causing Mitochondrial Disease More Common Than Previously Believed PITTSBURGH, Aug. 11 /PRNewswire-USNewswire/ -- The United Mitochondrial Disease Foundation (UMDF) today announced landmark research finding that one in every 200 people has a DNA mutation that could potentially cause...

(RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa

Led by Don MacKinnon, Founder of HEAR Music NEW YORK, June 30 /PRNewswire/ -- In the fall of 2008, (RED) will unveil a simple, seamless way for people to receive music from artists they love and artists they will discover through (RED). By applying the (RED) idea to music this ne...

Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADA's Recommended Target for Blood Sugar Control

New data presented at the ADA's Annual Scientific Sessions demonstrated the value of beginning insulin promptly when glycemic targets are not achieved with diet, exercise and oral medications alone SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- Results from a new study presented at...

Gene Therapy Provides Vision to People who Were Nearly Blind

Results of Clinical Trial Supported by the Foundation Fighting Blindness are Published in the New England Journal of Medicine OWINGS MILLS, Md., April 27 /PRNewswire/ -- Scientists employing a gene therapy have provided partial vision to patients who were nearly blind from a condition...

Treating Depression Prolongs Life for Older People with Diabetes

Also This Month: Lessons Learned from the Avandia Controversy ALEXANDRIA, Va., Nov. 27 /PRNewswire-USNewswire/ -- Depressed, older adults with diabetes live longer when they are treated for depression, according to a study in the December issue of Diabetes Care, which publishes on November...

LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity

Observational study published in the Annals of Surgery MELBOURNE, Australia, Nov. 21 /PRNewswire/ -- Severely obese people who received the LAP-BAND(R) Adjustable Gastric Banding System to lose weight had a 72 percent reduction in their risk of dying compared to obese people who were ...

38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty

Online press conference today with Mary Robinson, President, Realizing Rights, the ethical global initiative, Salil Shetty (UNMC) and Kumi Naidoo (GCAP) at 14.00GMT - log on at http://www.standagainstpoverty.org/press/conference NEW YORK, Oct. 18 /PRNewswire-USNewswire/ -- Over 38.7 millio...

New Resource Available for People With Lymphoma

FAIRFAX, Va., Aug. 2 /PRNewswire-USNewswire/ -- The American Society for Therapeutic Radiology and Oncology has published the brochure Radiation Therapy for Lymphoma, a short treatment guide to assist people coping with Hodgkin's and non-Hodgkin's lymphoma. The brochure outlines the major diff...

NIDA Study Identifies Genes That Might Help Some People Abstain from Smoking

Findings Move Science Closer to Targeted, Improved Therapies BETHESDA, Md., April 2, 2007--Scientists supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, have for the first time identified genes that might increase a person's ability to abstain fr...

New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia

Findings indicate early non-responders unlikely to subsequently respond, have substantially more treatment costs, and may benefit from earlier change in treatment strategy COLORADO SPRINGS, Colo., April 03, 2007 /PRNewswire-FirstCall/ -- New data presented at the 2007 International Congress on Sch...

Waismann Method Survey Reveals Dependency Risk for People Using Suboxone

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--May 31, 2007 - The Waismann Method today announced findings from an online survey of Suboxone users, indicating that 66 percent of individuals currently taking Suboxone, also known as Subutex or Buprenorphine, believe they cannot stop taking the drug without ...

Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes

- BYETTA also Showed Sustained Improvements in Blood Glucose Control and Progressive Weight Loss - CHICAGO, June 23, 2007 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study that showed BYETTA(R) (exenatide) injection sustained impr...

Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent

Results Highlighted in Oral Presentation at International Symposium of Thrombosis and Haemostasis GENEVA, July 10, 2007 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced the presentation of findings from the ADAPT (Analysis of Data from ADVATE(R) Prospective Trials) study pro...

Dean: President Bush Has Turned His Back on the American People

WASHINGTON, June 20, 2007 /PRNewswire-USNewswire/ -- Democratic National Committee Chairman Howard Dean issued the following statement today after President Bush once again put politics ahead of science by vetoing the Stem Cell Research Enhancement Act of 2007. The legislation, providing federal...

Regular Yoga Practice Is Associated With Mindful Eating

...ga practice is associated with mindful eating, and people who eat mindfully are less likely to be obese, acc...ay help prevent middle-age spread in normal-weight people and may promote weight loss in those who are overw... "In our earlier study, we found that middle-age people who practice yoga gained less weight over a 10-yea...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...ccines division of sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseas...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...e and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of pot...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

... - Program Focuses on Expanding Pipeline of Drugs For people with Type 1 Diabetes - NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- ...pand both the targets and the realm of possible treatments that can benefit people living with diabetes." Based in San Diego, GNF was founded in 1999...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

...ven by robust efficacy data in reducing fractures. About Osteoporosis Osteoporosis is a leading cause of morbidity and mortality in elderly people worldwide. In the U.S. alone, more than 44 million men and women have osteoporosis or low bone-mineral density. A 50-year-old woman in the U.S. has a ...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...latory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our assumptions regarding cash flow from oper...

DNA Helps Reunite Children With Their Families

... FORT WORTH, Texas, Aug. 4 /PRNewswire-USNewswire/ -- Of the 600,000-800,000 people trafficked across international borders each year, 50 percent are under 17. It is estimated that by 2010, human trafficking will be the No. 1 crime wo...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

...2 diabetes (formerly called non-insulin-dependent or adult-onset) results from the body's ineffective use of insulin. Type 2 diabetes comprises 90% of people with diabetes around the world, and is largely the result of excess body weight and physical inactivity. About Debiopharm Group Debiopha...

Scientists Discover Origin of Malaria

... said. "This makes the task of stopping future disease spillovers from animals to humans vital, not only for saving lives today, but for the health of people for many generations to come." Every year malaria: Accounts for 500 million cases per year. Results in more than one million...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...e to bone tissue where they settle and grow, occur in more than 1.5 million people worldwide.(1) With improvements in cancer care, including earlier diagnosis...gen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid ar...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...sts in men, or problems with erection. Some people may feel faint, dizzy, or may pass out when they s...way. INVEGA((R)) SUSTENNA(TM) can make some people feel dizzy, sleepy, or less alert. Until you know ...EGA((R)) SUSTENNA(TM) should be used cautiously in people with a seizure disorder, who have had seizures in ...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

...three subtypes according to the presence or absence of neurological involvement. It is also the most common genetic disease affecting Ashkenazi Jewish people (Eastern, Central and Northern European ancestry), with a carrier frequency of 1 in 10 (Dr. John Barranger and Dr. Ed Ginns 1989). This panethnic dise...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... thinking. The condition affects about 24 million people worldwide (or seven in every 1,000 adults in the population), including more than two million people in the United States and more than four million people in Europe. Although there are a number of medicat...

New Powder Speeds Healing of Difficult Foot Wounds

...es. Diabetic foot ulcers are the leading cause of non-traumatic, lower-limb amputations in the United States. In a recent APMA survey, 18 percent of people with diabetes reported that they have experienced a foot sore that would not heal. This powder's successful treatment of difficult foot wounds could p...

Is Your Hair Taking a Break?

... "Hair loss is a very misunderstood condition, both in terms of how people see their own hair loss and how physicians who are not dermatologists appro...men. Many of my patients report not going to church because they don't want people in the pew behind them to see their thinning hair, or they stop exercising ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... mesh wires, are then inserted into the aneurysm in order to prevent the space from filling with blood and rupturing. Approximately two million people in the United States have an unruptured aneurysm. It is estimated that approximately 30,000 Americans suffer from subarachnoid hemorrhage each year. ...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...fe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of pot...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... include vision problems, loss of balance, numbness, difficulty walking and paralysis(iii, iv). MS is thought to affect as many as 2.5 million people worldwide, including approximately 400,000 in the United States(v). It is a disease that affects more women than men, with onset typically occurring ...
Other TagsVariousAfghanRecommended
(Date:12/4/2009)... widely used by physicians and scientists to study brain ... remained largely unknown whether the electrodes on the head ... the brain. Scientists at the Max Planck Institute for ... crucial link between the activity generated within the brain ...
(Date:12/4/2009)... amyloids the fibrous protein deposits associated with diseases such ... potential new area for therapeutics. , It was believed that ... known as fibres - are inert, but that there may ... and cause disease. , But in a paper published ...
(Date:12/3/2009)... to changes in our daily environment, as well as to ... where nerve cells communicate, according to a new study by ... this week in the journal Nature . , ... physiology and neuroscience at NYU School of Medicine, discovered that ...
Breaking Biology News(10 mins):How to read brain activity? 2New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2Health Insurance Options for Domestic Partnerships 51188 1Health Insurance Options for Domestic Partnerships 51188 2Health Insurance Options for Domestic Partnerships 51188 3Help For Handicapped From New Company 51187 1Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 1Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 2Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 3Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 4Amylin Pharmaceuticals Announces Positive Results from Dose Ranging Clinical Study of Pramlintide Metreleptin Combination Treatment for Obesity 12950 5
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... Sickle cell disease, a condition characterized ... one of the most common genetic blood disorders ... more than 70,000 Americans.(1) Research presented today at ... of Hematology highlights intriguing studies on the acute ... with this blood disorder, evaluations of both new ...
(Date:12/6/2009)... Blood clotting, or coagulation, is an important process ... is injured. Sometimes, however, clots form on the ... do not dissolve naturally, a potentially life-threatening situation ... Annual Meeting of the American Society of Hematology ... aspirin and heparin with the hope of preventing ...
(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...
(Date:12/6/2009)... Disorders information and Treatment site www.sleeping-with-a-sleeping-disorder.com ... with herbal or natural sleep aids from around ... for a good cause. The submissions will be ... Aids ,Encyclopedia, by YOU, to be sold from ... will donate 100% of the proceeds ,from sales ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2
Other Contentsparenteralparenteralparenteralparesisparesthesiaparkinsonparoxysmparotid